Healthcare resource utilization and costs among children with cystic fibrosis in the United States.

"CONFLICT OF INTERESTS All authors received nonfinancial support (assistance with manuscript preparation) from ArticulateScience LLC, which received funding from Vertex Pharmaceuticals Incorporated. TT, LM, and JLR are employees of Vertex and may own stock or stock options in that company. MMB was an employee of IBM Watson Health Company at the time the study was conducted, which received a research contract to conduct this study with and on behalf of Vertex, and is a current employee of Veradigm Life Sciences. BLL and KJ‐P are employees of IBM Watson Health Company, which received a research contract to conduct this study with and on behalf of Vertex. MWK reports grants from Vertex, Laurent Pharmaceuticals, Anthera, Cystic Fibrosis Foundation, National Institutes of Health, and AzurRx; personal fees from Chiesi, Celtaxsys, Ionis Pharmaceuticals, Merck, Paranta Biosciences, Santhera, pH Pharma, Kala Pharmaceuticals, Vertex, Laurent Pharmaceuticals, Anthera, Cystic Fibrosis Foundation, and AzurRx; and serving on an advisory board for Vertex, Ionis Pharmaceuticals, Santhera, and Kala Pharmaceuticals, outside the submitted work."

"Augustine Obi, PharmD, of Vertex Pharmaceuticals Incorporated, provided editorial coordination and assistance. Amos Race, PhD, and Samantha Keller, PhD, of ArticulateScience LLC, provided editorial assistance under the direction of the authors, with support from Vertex Pharmaceuticals Incorporated. This study was supported by Vertex Pharmaceuticals Incorporated. Data from this study (for children aged 0 to <6 years) have been presented in posters at the ECFS 2019 (Liverpool, UK) and ISPOR 2019 (New Orleans, LA, USA) conferences."